Published: Tuesday, March 26, 2024 · 1:05 PM | Updated: Tuesday, March 26, 2024 · 1:05 PM
📊 639 views
Mar 05, 2024 / 04:10PM GMT
Daniel Gregory Brennan – TD Cowen, Research Division – MD and Senior Tools & Diagnostics Analyst
Thank you. Dan Brennan from TD Cowan Life Science Tools Diagnostics. And we’re here at 44th Annual Global Healthcare Conference. Really pleased to be joined here on the stage Rainer Blair, President and CEO of Danaher Corporation. So Rainer, thank you very much for being here.
Rainer M. Blair – Danaher Corporation – President, CEO & Director
Thanks, Dan. Good to see you.
Questions and Answers:
Daniel Gregory Brennan – TD Cowen, Research Division – MD and Senior Tools & Diagnostics Analyst
As a reminder, you took over CEO of Danaher back September 2020, in the middle of COVID, quite a volatile period. You set your steady-state growth rate high single digits back in, I think, the fall of 2022. Maybe just speak to the key drivers of that kind of growth rate, your confidence and then outlook given the continued end market volatility since it was offered?
Rainer M. Blair – Danaher
MORE IN INSIDE INVESTMENT NEWS
Anthropic Revenue Soars: Alpha Generation in AI’s Next Wave
Published: Saturday, August 15, 2026 · 11:17 AM
Cerebras stock Plunges 14%: Alpha Opportunity or IPO Warning?
Published: Thursday, August 13, 2026 · 2:04 PM
